Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Mindfulness for Stress
2024-513482-39-00Phase 2Authorised
- Sponsor
- UZ Leuven
- Start
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of oxytocin in distress, sponsored by UZ Leuven. Primary endpoint: Perceived Stress Scale (PSS). Planned start Mar 2025; status: authorised.
02
Drugs
oxytocin
03
Conditions
distress
Beyond the preview
Go deeper on 2024-513482-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513482-39-00.